By: Moncrief, Shapleigh S.B. No. 1763
A BILL TO BE ENTITLED
1-1 AN ACT
1-2 relating to the provision of information about patient assistance
1-3 programs offered by pharmaceutical companies.
1-4 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1-5 SECTION 1. Chapter 161, Health and Safety Code, is amended
1-6 by adding Subchapter Q to read as follows:
1-7 SUBCHAPTER Q. PROVISION OF INFORMATION ABOUT
1-8 PATIENT ASSISTANCE PROGRAMS
1-9 Sec. 161.381. DEFINITION. In this subchapter, "patient
1-10 assistance program" means a program offered by a pharmaceutical
1-11 company under which the company provides a drug to persons in need
1-12 of assistance at no charge or at a substantially reduced cost. The
1-13 term does not include the provision of a drug as part of a clinical
1-14 trial.
1-15 Sec. 161.382. PROVIDING INFORMATION TO DEPARTMENT. Each
1-16 pharmaceutical company that does business in this state and that
1-17 offers a patient assistance program shall inform the department of
1-18 the existence of the program, the eligibility requirements for the
1-19 program, the drugs covered by the program, and information such as
1-20 a telephone number used for applying for the program.
1-21 Sec. 161.383. TOLL-FREE TELEPHONE NUMBER. (a) The
1-22 department shall establish a system under which members of the
1-23 public can call a toll-free telephone number to obtain information
1-24 about available patient assistance programs. The department shall
1-25 ensure that the system is staffed at least during normal business
2-1 hours with persons who can:
2-2 (1) determine whether a patient assistance program is
2-3 offered for a particular drug;
2-4 (2) determine whether a person may be eligible to
2-5 participate in a program; and
2-6 (3) assist persons who wish to apply for a program.
2-7 (b) The department shall publicize the telephone number to
2-8 pharmacies and prescribers of drugs.
2-9 SECTION 2. This Act takes effect September 1, 2001.